Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 696

1.

Overload and automation-dependence in a multi-UAS simulation: Task demand and individual difference factors.

Lin J, Matthews G, Wohleber RW, Funke GJ, Calhoun GL, Ruff HA, Szalma J, Chiu P.

J Exp Psychol Appl. 2019 Oct 17. doi: 10.1037/xap0000248. [Epub ahead of print]

PMID:
31621357
2.

The ANT Executive Control Index: No Evidence for Temporal Decrement.

Zholdassova M, Kustubayeva A, Matthews G.

Hum Factors. 2019 Oct 8:18720819880058. doi: 10.1177/0018720819880058. [Epub ahead of print]

PMID:
31593487
3.

Moving towards hepatitis C micro-elimination among people living with HIV in Australia: the CEASE study.

Martinello M, Yee J, Bartlett SR, Read P, Baker D, Post JJ, Finlayson R, Bloch M, Doyle J, Shaw D, Hellard M, Petoumenos K, Lin L, Marks P, Applegate T, Dore GJ, Matthews GV; CEASE study team.

Clin Infect Dis. 2019 Oct 4. pii: ciz985. doi: 10.1093/cid/ciz985. [Epub ahead of print]

PMID:
31585005
4.

Comparing the effect of STan (cardiotocographic electronic fetal monitoring (CTG) plus analysis of the ST segment of the fetal electrocardiogram) with CTG alone on emergency caesarean section rates: study protocol for the STan Australian Randomised controlled Trial (START).

Turnbull D, Salter A, Simpson B, Mol BW, Chandraharan E, McPhee A, Symonds I, Benton M, Kuah S, Matthews G, Howard K, Wilkinson C.

Trials. 2019 Aug 29;20(1):539. doi: 10.1186/s13063-019-3640-9.

5.

Quantifying maladaptation during the evolution of sexual dimorphism.

Matthews G, Hangartner S, Chapple DG, Connallon T.

Proc Biol Sci. 2019 Aug 14;286(1908):20191372. doi: 10.1098/rspb.2019.1372. Epub 2019 Aug 14.

PMID:
31409252
6.

CE: Original Research: Are Milk and Molasses Enemas Safe for Hospitalized Adults? A Retrospective Electronic Health Record Review.

Wangui-Verry J, Farrington M, Matthews G, Tucker SJ.

Am J Nurs. 2019 Sep;119(9):24-28. doi: 10.1097/01.NAJ.0000580148.43193.76.

PMID:
31408025
7.

Patterns of drug, alcohol use and injection equipment sharing among people with recent injecting drug use or receiving opioid agonist treatment during and following hepatitis C virus treatment with direct-acting antiviral therapies: An international study.

Artenie AA, Cunningham EB, Dore GJ, Conway B, Dalgard O, Powis J, Bruggmann P, Hellard M, Cooper C, Read P, Feld JJ, Hajarizadeh B, Amin J, Lacombe K, Stedman C, Litwin AH, Marks P, Matthews GV, Quiene S, Erratt A, Bruneau J, Grebely J.

Clin Infect Dis. 2019 Jul 11. pii: ciz633. doi: 10.1093/cid/ciz633. [Epub ahead of print]

PMID:
31300820
8.

Tracking Newly Released Synaptic Vesicle Proteins at Ribbon Active Zones.

Vaithianathan T, Wollmuth LP, Henry D, Zenisek D, Matthews G.

iScience. 2019 Jul 26;17:10-23. doi: 10.1016/j.isci.2019.06.015. Epub 2019 Jun 13.

9.

A Comparison of the Effects of 45-minute Aerobic Training and Cognitive Task Solving on Transient Mood States in a Female Student Sample.

Stolarska B, Stolarski M, Matthews G.

Appl Psychol Health Well Being. 2019 Jun 11. doi: 10.1111/aphw.12165. [Epub ahead of print]

PMID:
31183962
10.

Cross-sex genetic correlations for fitness and fitness components: Connecting theoretical predictions to empirical patterns.

Connallon T, Matthews G.

Evol Lett. 2019 Apr 29;3(3):254-262. doi: 10.1002/evl3.116. eCollection 2019 Jun.

11.

Becoming Better Messengers: The Public Health Advantage.

Burris S, Matthews G, Gunderson G, Baker EL.

J Public Health Manag Pract. 2019 Jul/Aug;25(4):402-404. doi: 10.1097/PHH.0000000000001032. No abstract available.

PMID:
31136515
12.

Confidence Intervals for the Area Under the Receiver Operating Characteristic Curve in the Presence of Ignorable Missing Data.

Cho H, Matthews GJ, Harel O.

Int Stat Rev. 2019 Apr;87(1):152-177. doi: 10.1111/insr.12277. Epub 2018 Aug 9.

13.

Metastatic Colorectal Adenocarcinoma in a Bifid Ureter.

Gopal N, Stern M, Patel NH, Matthews G, Eshghi M.

J Endourol Case Rep. 2019 Mar 18;5(1):13-15. doi: 10.1089/cren.2018.0100. eCollection 2019.

14.

Metacognition, Hardiness, and Grit as Resilience Factors in Unmanned Aerial Systems (UAS) Operations: A Simulation Study.

Matthews G, Panganiban AR, Wells A, Wohleber RW, Reinerman-Jones LE.

Front Psychol. 2019 Mar 26;10:640. doi: 10.3389/fpsyg.2019.00640. eCollection 2019.

15.

Unveiling the Interfacial Effects for Enhanced Hydrogen Evolution Reaction on MoS2 /WTe2 Hybrid Structures.

Zhou Y, Pondick JV, Silva JL, Woods JM, Hynek DJ, Matthews G, Shen X, Feng Q, Liu W, Lu Z, Liang Z, Brena B, Cai Z, Wu M, Jiao L, Hu S, Wang H, Araujo CM, Cha JJ.

Small. 2019 May;15(19):e1900078. doi: 10.1002/smll.201900078. Epub 2019 Apr 8.

PMID:
30957970
16.

Patient, Nurse, and Organizational Factors That Influence Evidence-Based Fall Prevention for Hospitalized Oncology Patients: An Exploratory Study.

Tucker S, Sheikholeslami D, Farrington M, Picone D, Johnson J, Matthews G, Evans R, Gould R, Bohlken D, Comried L, Petrulevich K, Perkhounkova E, Cullen L.

Worldviews Evid Based Nurs. 2019 Apr;16(2):111-120. doi: 10.1111/wvn.12353. Epub 2019 Mar 27.

PMID:
30919563
17.

Quinidine Rebooted: Contemporary Approaches to Multichannel Blockade.

Grace AA, Matthews GDK.

JACC Clin Electrophysiol. 2019 Mar;5(3):383-386. doi: 10.1016/j.jacep.2019.01.015. No abstract available.

PMID:
30898242
18.

Neural mechanisms of social homeostasis.

Matthews GA, Tye KM.

Ann N Y Acad Sci. 2019 Mar 15. doi: 10.1111/nyas.14016. [Epub ahead of print] Review.

PMID:
30875095
19.

MRI of the Wrist: Algorithmic Approach for Evaluating Wrist Pain.

Matthews GS, Kiani B, Wuertzer SD, Powell JA, Roller BL, Lenchik L, Torabi M.

Radiographics. 2019 Mar-Apr;39(2):447-448. doi: 10.1148/rg.2019180157. No abstract available.

PMID:
30844354
20.

Can Australia reach the World Health Organization Hepatitis C elimination goal by 2025 among HIV-positive gay and bisexual men?

Boettiger DC, Salazar-Vizcaya L, Dore GJ, Gray RT, Law MG, Callander D, Lea T, Rauch A, Matthews GV.

Clin Infect Dis. 2019 Feb 28. pii: ciz164. doi: 10.1093/cid/ciz164. [Epub ahead of print]

PMID:
30816916
21.

A latent class approach to identify multi-risk profiles associated with phylogenetic clustering of recent hepatitis C virus infection in Australia and New Zealand from 2004 to 2015.

Bartlett SR, Applegate TL, Jacka BP, Martinello M, Lamoury FM, Danta M, Bradshaw D, Shaw D, Lloyd AR, Hellard M, Dore GJ, Matthews GV, Grebely J.

J Int AIDS Soc. 2019 Feb;22(2):e25222. doi: 10.1002/jia2.25222.

22.

Millennials as New Messengers for Public Health.

Boufides CH, Corcoran E, Matthews GW, Herrick J, Baker EL.

J Public Health Manag Pract. 2019 Mar/Apr;25(2):197-200. doi: 10.1097/PHH.0000000000000964. No abstract available.

PMID:
30720593
23.

Management of acute HCV in the era of direct-acting antivirals: implications for elimination.

Martinello M, Matthews GV.

Lancet Gastroenterol Hepatol. 2019 Apr;4(4):256-257. doi: 10.1016/S2468-1253(19)30001-9. Epub 2019 Jan 17. No abstract available.

PMID:
30660618
24.

A systematic, deep sequencing-based methodology for identification of mixed-genotype hepatitis C virus infections.

Olmstead AD, Montoya V, Chui CK, Dong W, Joy JB, Tai V, Poon AFY, Nguyen T, Brumme CJ, Martinello M, Matthews GV, Richard Harrigan P, Dore GJ, Applegate TL, Grebely J, Howe AYM.

Infect Genet Evol. 2019 Apr;69:76-84. doi: 10.1016/j.meegid.2019.01.016. Epub 2019 Jan 14.

PMID:
30654177
25.

Looking at the positives: proactive management of STIs in people with HIV.

Khaw C, Richardson D, Matthews G, Read T.

AIDS Res Ther. 2018 Dec 21;15(1):28. doi: 10.1186/s12981-018-0216-9. Review.

26.

Improved isotopic model based on 15 N tracing and Rayleigh-type isotope fractionation for simulating differential sources of N2 O emissions in a clay grassland soil.

Castellano-Hinojosa A, Loick N, Dixon E, Matthews GP, Lewicka-Szczebak D, Well R, Bol R, Charteris A, Cardenas L.

Rapid Commun Mass Spectrom. 2019 Mar 15;33(5):449-460. doi: 10.1002/rcm.8374.

27.

Sexually transmitted hepatitis C infection: the evolving epidemic in HIV-positive and HIV-negative MSM.

Lockart I, Matthews GV, Danta M.

Curr Opin Infect Dis. 2019 Feb;32(1):31-37. doi: 10.1097/QCO.0000000000000515.

PMID:
30531370
28.

Workload and Performance: Associations, Insensitivities, and Dissociations.

Hancock PA, Matthews G.

Hum Factors. 2019 May;61(3):374-392. doi: 10.1177/0018720818809590. Epub 2018 Dec 6.

PMID:
30521400
29.

Validation of epigenetic markers to identify colitis associated cancer: Results of module 1 of the ENDCAP-C study.

Beggs AD, Mehta S, Deeks JJ, James JD, Caldwell GM, Dilworth MP, Stockton JD, Blakeway D, Pestinger V, Vince A, Taniere P, Iqbal T, Magill L, Matthews G, Morton DG; ENDCAP-C Module 1 Collaborative.

EBioMedicine. 2019 Jan;39:265-271. doi: 10.1016/j.ebiom.2018.11.034. Epub 2018 Nov 22.

30.

Dopamine enhances signal-to-noise ratio in cortical-brainstem encoding of aversive stimuli.

Vander Weele CM, Siciliano CA, Matthews GA, Namburi P, Izadmehr EM, Espinel IC, Nieh EH, Schut EHS, Padilla-Coreano N, Burgos-Robles A, Chang CJ, Kimchi EY, Beyeler A, Wichmann R, Wildes CP, Tye KM.

Nature. 2018 Nov;563(7731):397-401. doi: 10.1038/s41586-018-0682-1. Epub 2018 Nov 7.

31.

Paritaprevir, ritonavir, ombitasvir, and dasabuvir with and without ribavirin in people with HCV genotype 1 and recent injecting drug use or receiving opioid substitution therapy.

Grebely J, Conway B, Cunningham EB, Fraser C, Moriggia A, Gane E, Stedman C, Cooper C, Castro E, Schmid P, Petoumenos K, Hajarizadeh B, Marks P, Erratt A, Dalgard O, Lacombe K, Feld JJ, Bruneau J, Daulouede JP, Powis J, Bruggmann P, Matthews GV, Kronborg I, Shaw D, Dunlop A, Hellard M, Applegate TL, Crawford S, Dore GJ; D3FEAT Study Group.

Int J Drug Policy. 2018 Dec;62:94-103. doi: 10.1016/j.drugpo.2018.10.004. Epub 2018 Oct 29.

PMID:
30384028
32.

Sociodemographic and clinical correlates of the frequently hospitalized African American patients with severe and persistent mental illness.

de Similien R, Hairston DR, Kumari S, Matthews GE, Wasser T, Malik M, Manalai P.

Ann Clin Psychiatry. 2018 Nov;30(4):305-310.

PMID:
30372508
33.

Adherence to sofosbuvir and velpatasvir among people with chronic HCV infection and recent injection drug use: The SIMPLIFY study.

Cunningham EB, Amin J, Feld JJ, Bruneau J, Dalgard O, Powis J, Hellard M, Cooper C, Read P, Conway B, Dunlop AJ, Norton B, Litwin AH, Hajarizadeh B, Thurnheer MC, Dillon JF, Weltman M, Shaw D, Bruggmann P, Gane E, Fraser C, Marks P, Applegate TL, Quiene S, Siriragavan S, Matthews GV, Dore GJ, Grebely J; SIMPLIFY study group.

Int J Drug Policy. 2018 Dec;62:14-23. doi: 10.1016/j.drugpo.2018.08.013. Epub 2018 Oct 22.

PMID:
30352330
34.

An in-depth look into the association between morningness-eveningness and well-being: evidence for mediating and moderating effects of personality.

Drezno M, Stolarski M, Matthews G.

Chronobiol Int. 2019 Jan;36(1):96-109. doi: 10.1080/07420528.2018.1523184. Epub 2018 Oct 10.

PMID:
30303401
35.

Benefit of Early versus Deferred Antiretroviral Therapy on Progression of Liver Fibrosis among People with HIV in the START Randomized Trial.

Dharan NJ, Neuhaus J, Rockstroh JK, Peters L, Gordin F, Arenas-Pinto A, Emerson C, Marks K, Hidalgo J, Sarmento-Castro R, Stephan C, Kumarasamy N, Emery S, Matthews GV; INSIGHT START Study Group.

Hepatology. 2019 Mar;69(3):1135-1150. doi: 10.1002/hep.30296. Epub 2019 Feb 19.

36.

Genome Editing Reveals Idiosyncrasy of CNGA2 Ion Channel-Directed Antibody Immunoreactivity Toward Oxytocin.

Blechman J, Anbalagan S, Matthews GG, Levkowitz G.

Front Cell Dev Biol. 2018 Sep 20;6:117. doi: 10.3389/fcell.2018.00117. eCollection 2018.

37.

Vigilance and Automation Dependence in Operation of Multiple Unmanned Aerial Systems (UAS): A Simulation Study.

Wohleber RW, Matthews G, Lin J, Szalma JL, Calhoun GL, Funke GJ, Chiu CP, Ruff HA.

Hum Factors. 2019 May;61(3):488-505. doi: 10.1177/0018720818799468. Epub 2018 Sep 28.

PMID:
30265579
38.

Avian predation intensity as a driver of clinal variation in colour morph frequency.

Matthews G, Goulet CT, Delhey K, Atkins ZS, While GM, Gardner MG, Chapple DG.

J Anim Ecol. 2018 Nov;87(6):1667-1684. doi: 10.1111/1365-2656.12894. Epub 2018 Sep 10.

PMID:
30098209
39.

Origin of metastable oligomers and their effects on amyloid fibril self-assembly.

Hasecke F, Miti T, Perez C, Barton J, Schölzel D, Gremer L, Grüning CSR, Matthews G, Meisl G, Knowles TPJ, Willbold D, Neudecker P, Heise H, Ullah G, Hoyer W, Muschol M.

Chem Sci. 2018 Jun 13;9(27):5937-5948. doi: 10.1039/c8sc01479e. eCollection 2018 Jul 21.

40.

Modelling the impact of larviciding on the population dynamics and biting rates of Simulium damnosum (s.l.): implications for vector control as a complementary strategy for onchocerciasis elimination in Africa.

Routledge I, Walker M, Cheke RA, Bhatt S, Nkot PB, Matthews GA, Baleguel D, Dobson HM, Wiles TL, Basañez MG.

Parasit Vectors. 2018 May 29;11(1):316. doi: 10.1186/s13071-018-2864-y.

41.

Prostate Cancer Screening Trends After United States Preventative Services Task Force Guidelines in an Underserved Population.

Patel NH, Bloom J, Hillelsohn J, Fullerton S, Allman D, Matthews G, Eshghi M, Phillips JL.

Health Equity. 2018 May 1;2(1):55-61. doi: 10.1089/heq.2018.0004. eCollection 2018.

42.

Strategies to Reduce Hepatitis C Virus Reinfection in People Who Inject Drugs.

Martinello M, Dore GJ, Matthews GV, Grebely J.

Infect Dis Clin North Am. 2018 Jun;32(2):371-393. doi: 10.1016/j.idc.2018.02.003. Review.

PMID:
29778261
43.

Management of acute HCV infection in the era of direct-acting antiviral therapy.

Martinello M, Hajarizadeh B, Grebely J, Dore GJ, Matthews GV.

Nat Rev Gastroenterol Hepatol. 2018 Jul;15(7):412-424. doi: 10.1038/s41575-018-0026-5. Review.

PMID:
29773899
44.

Discovery and Validation of Methylation Biomarkers for Ulcerative Colitis Associated Neoplasia.

Beggs AD, James J, Caldwell G, Prout T, Dilworth MP, Taniere P, Iqbal T, Morton DG, Matthews G.

Inflamm Bowel Dis. 2018 Jun 8;24(7):1503-1509. doi: 10.1093/ibd/izy119.

45.

CE: Original Research: Exploring Clinicians' Perceptions About Sustaining an Evidence-Based Fall Prevention Program.

Porter RB, Cullen L, Farrington M, Matthews G, Tucker S.

Am J Nurs. 2018 May;118(5):24-33. doi: 10.1097/01.NAJ.0000532806.35972.29.

PMID:
29664739
46.

Shortened therapy of eight weeks with paritaprevir/ritonavir/ombitasvir and dasabuvir is highly effective in people with recent HCV genotype 1 infection.

Martinello M, Bhagani S, Gane E, Orkin C, Cooke G, Dore GJ, Petoumenos K, Applegate TL, Tu E, Marks P, Pagani N, Grebely J, Nelson M, Matthews GV.

J Viral Hepat. 2018 Oct;25(10):1180-1188. doi: 10.1111/jvh.12917. Epub 2018 May 8.

PMID:
29660224
47.

Dangerous intersections? A review of studies of fatigue and distraction in the automated vehicle.

Matthews G, Neubauer C, Saxby DJ, Wohleber RW, Lin J.

Accid Anal Prev. 2019 May;126:85-94. doi: 10.1016/j.aap.2018.04.004. Epub 2018 Apr 10. Review.

PMID:
29653675
48.

Phenotypic Landscape and Risk Management in Long QT Syndrome: Nudging Forward.

Grace AA, Matthews GDK.

J Am Coll Cardiol. 2018 Apr 17;71(15):1672-1675. doi: 10.1016/j.jacc.2018.02.040. No abstract available.

49.

Linkage and retention in HCV care for HIV-infected populations: early data from the DAA era.

Sacks-Davis R, Doyle JS, Rauch A, Beguelin C, Pedrana AE, Matthews GV, Prins M, van der Valk M, Klein MB, Saeed S, Lacombe K, Chkhartishvili N, Altice FL, Hellard ME.

J Int AIDS Soc. 2018 Apr;21 Suppl 2:e25051. doi: 10.1002/jia2.25051.

50.

Post-Brexit crystal ball gazing: The future for phase 1 clinical trials in the UK.

Matthews G, Williams N.

Med Leg J. 2018 Jun;86(2):63-71. doi: 10.1177/0025817218767265. Epub 2018 Mar 29. No abstract available.

PMID:
29595365

Supplemental Content

Loading ...
Support Center